Home / Healthcare / Pharmaceutical / U.S. Prescription Drugs Market
U.S. Prescription Drugs Market Size, Share & COVID-19 Impact Analysis, By Product Type (Generic Drugs, Orphan Drugs, and Other Prescription Drugs), By Therapy Area (Oncology, Central Nervous System, Vaccines, Immunosuppressants, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Country Forecast, 2023-2030
Report Format: PDF | Published Date: Feb, 2024 | Report ID: FBI108971. | Status : PublishedSummary
TOC
Methodology
Market Segmentation
Frequently Asked Questions
How much was the U.S. prescription drugs market worth in 2022?
According to Fortune Business Insights, the global market size was USD 461.33 billion in 2022.
At what CAGR is the U.S. prescription drugs market projected to grow in the forecast period (2023-2030)?
The market is expected to exhibit a CAGR of 7.3% in the forecast period (2023-2030).
What is the leading segment in the market?
By product type, the other prescription drugs segment is the leading segment of the market.
Who are the leading players in the market?
Novartis AG and Pfizer, Inc. are the leading players in the U.S. market.
- 2022
- 2019-2021
- 70